[ Price : $8.95]
FDA approves a Boehringer Ingelheim Pharmaceuticals NDA for Combivent Respimat (ipratropium bromide and albuterol), a new propella...[ Price : $8.95]
Massachusetts federal court grants a temporary restraining order to prevent Watson Pharmaceuticals and Amphastar from marketing Am...[ Price : $8.95]
FDA grants a fast track designation for DARA BioSciences' KRN5500 for treating neuropathic pain in patients with cancer.[ Price : $8.95]
FDA approves an Onco Therapies ANDA for a generic copy of Janssen's Luestatin.[ Price : $8.95]
FDA accepts for review a Banner Pharmacaps ANDA for a generic version of Eisai's Targretin.[ Price : $8.95]
FDA maintains a clinical hold on an Insmed Phase 3clinical trial for Arikace (liposomal amikacin for inhalation) in cystic fibrosi...[ Price : $8.95]
FDA clears a Cardium Therapeutics 510(k) for the Excellagen professional-use, sterile, syringe-based advanced wound care product f...[ Price : $8.95]
FDA approves an MSD International GmbH Clonmel NDA for Juvisync (sitagliptin and simvastatin), a fixed-dose convenience combinatio...